Details

Autor(en) / Beteiligte

• Sepahi, Samaneh
• Kiaei, Lily
• Kiaei, Mahmoud
• Ghorani-Azam, Adel

Titel

A systematic review of emerging technologies to enhance the treatment of ovarian cancer

Ist Teil von

• Pharmaceutical development and technology, 2023-08, Vol.ahead-of-print (ahead-of-print), p.1-18

Ort / Verlag

England: Taylor & Francis

Erscheinungsjahr

2023

Quelle

EBSCOhost Business Source Ultimate

Beschreibungen/Notizen

• The efficacy and safety of chemotherapy are two major challenges when it comes to treating ovarian cancer. The associated undesirable side effects of chemotherapy agents jeopardize the clinical intent and the efficiency of the therapy. Multiple studies have been published describing new developments and novel strategies utilizing the latest therapeutic and drug delivery technologies to address the efficacy and safety of chemotherapeutics in ovarian cancers. We have identified five novel technologies that are available and, if used, have the potential to mitigate the above-mentioned challenges. Nanocarriers in different forms (Nano-gel, Aptamer, peptide medicated formulations, Antibody-drug conjugation, surface charge, and nanovesicle technologies) are developed and available to be employed to target the cancerous tissue. These strategies are promising to improve clinical efficacy and reduce side effects. We have systematically searched and analyzed published data, as well as the authors intent for the described technology on each publication. We narrowed to 81 key articles and extracted their data to be discussed in this review. In summary, the selected articles investigated the pharmacokinetic properties of drugs combined with nanocarriers and found significant improvement in efficacy and safety by reducing the IC50 values and drug doses. These key papers described promising novel technologies in anti-cancer therapeutic approaches to enable sustained drug release and achieve prolonged drug performance near the tumor site or target tissue.